Phase I Trial of MS-275, a Histone Deacetylase Inhibitor,...

Clinical Cancer Research 2007 / 09 Vol. 13; Iss. 18

Phase I Trial of MS-275, a Histone Deacetylase Inhibitor, Administered Weekly in Refractory Solid Tumors and Lymphoid Malignancies

Kummar, S., Gutierrez, M., Gardner, E. R., Donovan, E., Hwang, K., Chung, E. J., Lee, M.-J., Maynard, K., Kalnitskiy, M., Chen, A., Melillo, G., Ryan, Q. C., Conley, B., Figg, W. D., Trepel, J. B., Zw
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-07-0791
Date:
September, 2007
File:
PDF, 241 KB
english, 2007
Conversion to is in progress
Conversion to is failed